NSC668394

Research use only, not for human use.

NSC668394 (NSC 668394) is a small molecule inhibitor of ezrin, directly bind to ezrin with Kd of 12.59 uM.

NSC668394 (NSC 668394) is a small molecule inhibitor of ezrin, directly bind to ezrin with Kd of 12.59 uM; inhibits T567 phosphorylation and actin binding of endogenous ezrin at 10 μM without altering cellular ezrin levels, inhibits PKC-Ι phosphorylation of recombinant ezrin with IC50 of 8.1 uM; inhibits ezrin-mediated invasion of K7M2 OS cells, inhibits cell motility during zebrafish and Xenopus embryonic development; also inhibits ezrin-dependent in vivo OS metastatic growth in mouse lung.

Western Blot Analysis Cell Line:K7M2 OS cells Concentration:10 μM Incubation Time:6 hours Result:Inhibited T567 phosphorylation and actin binding of endogenous ezrin without altering cellular ezrin levels.

Animal Model:Female BALB/c and SCID/Beige mice were injected with K7M2 or MNNG-HOS tumor cellsDosage:0.226 mg/kg/day Administration:I.p. 5-days a week for 66 days Result:Showed an increase in survival.Decreased the number of the green fluorescent protein (GFP)-expressing metastatic foci in the lung tissues.

NSC 668394 | NSC-668394

Cytoskeleton/Cell Adhesion Molecules

Ezrin

Ezrin

——

——

382605-72-3

452.102

C17H12Br2N2O3

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (110.60 mM)

O=C(C=C1NCCC2=CC(Br)=C(O)C(Br)=C2)C3=C(N=CC=C3)C1=O

7-((3,5-dibromo-4-hydroxyphenethyl)amino)quinoline-5,8-dione

(-20℃)

With Ice Pack

≥ 2 years